Medrio Unveils Enhanced RTSM Features for Swift Clinical Trials and Increased Adaptability

Medrio Enhances RTSM for Clinical Trials

Medrio, a leading player in the clinical trial technology sector, recently introduced significant upgrades to its randomization and trial supply management (RTSM) solution. These enhancements are primarily designed to facilitate faster implementation and greater flexibility, as well as to improve self-service options for research teams.

Need for Speed and Flexibility

In an increasingly complex landscape where 77% of clinical trials require moderate to high-complexity RTSM setups, speed and adaptability have become essential. Nicole Latimer, CEO of Medrio, articulated this need well, stating, "Our customers need RTSM to be as agile as the trials they run." The new features allow teams to configure, test, and deploy Medrio RTSM in a considerably shorter timeframe than traditional systems, enabling them to achieve these tasks without the extensive reliance on vendor support that has characterized the industry for so long.

Tackling Complexity with No-Code Solutions

The upgrades are particularly user-centric, stemming from direct collaboration with clients. Medrio's novel no-code configurability allows sponsors and Clinical Research Organizations (CROs) to build and deploy their RTSM solutions in weeks instead of months. Kenneth Homer, Director of Biostatistics and Programming at Homer Biometrics, endorses this approach, praising the professionalism and flexibility of the Medrio RTSM build team. He highlighted that the upcoming front-end features would empower users to configure the RTSM system on-demand, a game-changer for satisfying client needs.

Seamless Integration with Medrio CDMS/EDC

Furthermore, Medrio RTSM boasts seamless integration with the Medrio CDMS/EDC platform, creating a unified trial management experience. This connection minimizes data silos, significantly streamlining reconciliation efforts and ensuring real-time data synchronization. The enhanced solution incorporates automated supply management features and point-and-click configurability, ensuring that research teams can quickly adapt to any changes in study protocols while maintaining meticulous oversight and control.

A Commitment to Enhanced Efficiency

These latest improvements reflect Medrio's dedication to driving clinical trial efficiency. Innovations like AI-enabled reporting streamline operations and further reduce study timelines, allowing research teams to focus on producing high-quality data expeditiously. By addressing the barriers of speed and usability, Medrio paves the way for faster trial execution.

Availability and Future Enhancements

The enhanced RTSM is now available, with additional self-service functionalities set to be rolled out throughout 2025. Customers can take advantage of tiered enablement packages and expert support to optimize their RTSM workflows. Medrio is inviting potential users to request demos to explore how these new features can assist in accelerating timelines, simplifying processes, and enhancing overall trial execution capabilities.

About Medrio

With a mission to improve 100 million lives through efficient and secure clinical trials, Medrio serves sponsors, CROs, and research sites on a global scale. Nearly two decades of experience in the field allows Medrio to deliver scalable solutions that integrate industry-leading support and insight. Offering a comprehensive suite of solutions—including CDMS/EDC, eCOA/ePRO, eConsent, and RTSM—Medrio ensures the capture of quality clinical trial data while optimizing workflows for regulatory readiness. Embrace the efficiency of Medrio and realize the true potential of your clinical operations.

For more information, visit Medrio's official website or contact their team for any further inquiries.